Concepedia

Soizick Mesnage

SM

Statistics

Publications

7

Citations

421

H-Index

7

Active since

2015

Affiliations

Inserm(Current)

Institut Gustave Roussy

Université Paris-Saclay

Auckland City Hospital

Soizick Mesnage is an author at Inserm specializing in oncology, medicine, and ovarian cancer.

Publications per year

2015–2020

7

Publications

7

Neoadjuvant chemotherapy (NACT) increases immune infiltration and programmed death-ligand 1 (PD-L1) expression in epithelial ovarian cancer (EOC)

Soizick Mesnage, Aurélie Auguste, Catherine Genestie et al. · Annals of Oncology · 2016 · 173 citations · Full text

, , +17

Stage I granulosa cell tumours: A management conundrum? Results of long-term follow up

Michelle Wilson, Peter C.C. Fong, Soizick Mesnage et al. · Gynecologic Oncology · 2015 · 73 citations

, , +8

Changes in DNA Damage Response Markers with Treatment in Advanced Ovarian Cancer

Paul Kubelac, Catherine Genestie, Aurélie Auguste et al. · Cancers · 2020 · 52 citations · Full text

, , +17

Neoadjuvant chemotherapy alters the balance of effector to suppressor immune cells in advanced ovarian cancer

Alexandra Léary, Catherine Genestie, Félix Blanc‐Durand et al. · Cancer Immunology Immunotherapy · 2020 · 51 citations · Full text

, , +17

Distribution of novel immune-checkpoint targets in ovarian cancer tumor microenvironment: A dynamic landscape.

Félix Blanc‐Durand, Catherine Genestie, E. Yaniz Galende et al. · Gynecologic Oncology · 2020 · 51 citations

, , +16

1–5 of 7